DEF 14AThe Ballot
Seres Therapeutics, Inc. files DEF 14A
Filed Apr 29, 2022 · 4y ago · Accession 0001193125-22-133526
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Seres Therapeutics, Inc.
- Ticker
- MCRB
- CIK
- 1609809
- Form type
- DEF 14A
- Filing date
- Apr 29, 2022
- Report date
- Jun 22, 2022
- Document
- d244531ddef14a.htm
- Size
- 592 KB